Biomedical Research: NIH Should Publicly Report More Information about the Licensing of Its Intellectual Property (STAA) - Policy Briefs & Reports

Biomedical Research: NIH Should Publicly Report More Information about the Licensing of Its Intellectual Property
Biomedical Research: NIH Should Publicly Report More Information about the Licensing of Its Intellectual Property, Report no. GAO-21-52, October 2020
Research conducted at Department of Health and Human Services (HHS) labs led to 4,446 U.S. patents owned by the agency covering a range of inventions from 1980 through 2019. During that period, the National Institutes of Health (NIH) had 93 patents—2 percent of the total—that contributed to the successful development of 34 drugs approved by the Food and Drug Administration (FDA) and brought to market, including vaccines and treatments for cancer.

Biomedical Research: NIH Should Publicly Report More Information about the Licensing of Its Intellectual Property

Biomedical Research: NIH Should Publicly Report More Information about the Licensing of Its Intellectual Property, Report no. GAO-21-52, October 2020

Research conducted at Department of Health and Human Services (HHS) labs led to 4,446 U.S. patents owned by the agency covering a range of inventions from 1980 through 2019. During that period, the National Institutes of Health (NIH) had 93 patents—2 percent of the total—that contributed to the successful development of 34 drugs approved by the Food and Drug Administration (FDA) and brought to market, including vaccines and treatments for cancer.

Publication type:: project report
Publication language:: English
Publication date:: 2020
Publication URL:: https://www.gao.gov/assets/gao-21-52.pdf
Institute:: Science, Technology Assessment, and Analytics team of the U.S. Government Accountability Office (GAO) (STAA)
Country:: United States of America
Project:: Biomedical Research: NIH Should Publicly Report More Information about the Licensing of Its Intellectual Property (STAA)